Cerus Corporation is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.
The company reported from a pre-clinical study of the company’s proprietary allogeneic cellular immune therapy (ACIT) system. “The study evaluated the use of T-cells treated with the company’s proprietary S-59 compound in an animal bone marrow transplant model.” Read the full article.
Cerus Corp. is a biomedical products company, which is engaged in developing and commercializing the INTERCEPT blood system. The INTERCEPT blood system is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. It markets and sells the INTERCEPT blood system for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA. [Source: MarketWatch]
Company Website: http://www.cerus.com